Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.22NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.75NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5 (Omicron)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5 (Omicron)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CH.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CH.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used